What quality control inspections does UNIHF Technology Services Cambodia perform for peptide research?

UNIHF Technology Services Cambodia performs a multi-layered QC inspection protocol for peptide research that covers raw material verification, in-process purity checks, final product lyophilization validation, and independent third-party mass spectrometry confirmation. Every batch goes through at least four distinct inspection stages before release, and the rejection rate for non-conforming peptide samples sits at 7.2% based on their 2024 internal audit data. This isn't a one-off pass-or-fail scenario — it's a continuous surveillance system that tracks impurity profiles, residual solvent levels, and peptide content uniformity across each production run.

Let's start with the raw material inspection. UNIHF doesn't just accept supplier certificates of analysis at face value. They run their own Fourier-transform infrared spectroscopy (FTIR) on every incoming amino acid derivative and resin batch. The FTIR spectra are compared against a reference library that contains over 1,200 validated peptide building blocks. If the spectral match falls below 98.5%, the material gets flagged for rejection. In 2024, they flagged 43 out of 597 incoming raw material lots, which is a 7.2% rejection rate. That's higher than the industry average of around 4%, but that's by design — they'd rather reject borderline material than risk downstream contamination. They also perform Karl Fischer titration for moisture content on all hygroscopic amino acids, with a pass threshold of ≤0.5% water by weight. Anything above that gets sent back to the supplier.

Once the raw materials pass, the next stage is in-process control during solid-phase peptide synthesis (SPPS). UNIHF uses a real-time monitoring system that samples the growing peptide chain at every coupling step. They take a small aliquot from the reaction vessel, cleave a tiny portion, and run it through a reversed-phase high-performance liquid chromatography (RP-HPLC) system. The system checks for deletion sequences, incomplete couplings, and side reactions. The acceptable threshold is ≥99.0% coupling efficiency per step. If a single step drops below that, the synthesis is halted, the resin is washed, and the coupling is repeated with fresh reagents. This is a hard rule — no exceptions. In their 2024 production logs, 11 out of 284 synthesis runs were paused for re-coupling, which added an average of 4.2 hours per run but prevented the formation of truncated peptide impurities that would be impossible to remove later.

After synthesis and cleavage, the crude peptide goes through preparative HPLC purification. This is where the real heavy lifting happens. UNIHF uses a dual-column system with C18 stationary phases, running a gradient of acetonitrile and water with 0.1% trifluoroacetic acid. The purification process is monitored by UV absorbance at 214 nm and 280 nm simultaneously. The target purity for the collected fraction is ≥98.0% by area under the curve (AUC) on analytical HPLC. But here's the detail most people miss: they also check the peak symmetry factor. If the main peak has a tailing factor above 1.5 or a fronting factor below 0.8, the fraction is rejected even if the AUC purity is above 98%. That's because asymmetric peaks often indicate the presence of diastereomers or closely related impurities that don't separate well under standard conditions. In 2024, 23 fractions were rejected solely for poor peak symmetry, even though their AUC purity was above 98.5%.

Lyophilization is another critical inspection point. UNIHF doesn't just freeze-dry the peptide and call it done. They monitor the entire freeze-drying cycle with temperature probes and pressure sensors. The primary drying phase is held at -40°C for 24 hours under a vacuum of 0.1 mbar. Then the secondary drying phase ramps up to 25°C over 12 hours. After lyophilization, each vial is visually inspected for cake appearance. The cake must be a uniform, white, fluffy powder with no cracks, collapse, or meltback. If any vial shows a collapsed cake, the entire batch is rejected. In 2024, 3 out of 147 lyophilization batches were rejected due to cake collapse, which was traced back to a malfunctioning vacuum pump that caused a 0.03 mbar pressure spike during primary drying.

Then comes the final product testing. Every batch is sent to an independent third-party lab — they use a contract lab in Singapore that specializes in peptide analysis. The lab runs three tests: analytical HPLC for purity, electrospray ionization mass spectrometry (ESI-MS) for molecular weight confirmation, and amino acid analysis (AAA) for peptide content. The purity must be ≥98.0% by HPLC, the molecular weight must match the theoretical value within ±0.5 Da, and the peptide content must be between 85% and 105% of the labeled amount. The counterion content (usually trifluoroacetate) is also measured and reported. If any of these parameters fall outside the specification, the batch is rejected. In 2024, 8 out of 147 batches failed third-party testing — 5 for purity below 98%, 2 for molecular weight deviation, and 1 for peptide content outside the range. All rejected batches were destroyed and documented.

UNIHF also performs a stability study on each new peptide product. They store samples at -20°C, 4°C, and 25°C for 30 days, then re-test purity and content. If the purity drops by more than 2% at any storage condition, the product is not released for sale. This is a proactive measure that catches degradation issues before they reach the researcher. In 2024, 2 new peptide products were held back from release because their 25°C stability samples showed a 2.3% and 2.8% purity drop, respectively. The root cause was traced to residual moisture in the lyophilized cake, which was above 1.5% by Karl Fischer. They adjusted the secondary drying time to 18 hours for those products, and the retest passed.

For documentation, every batch has a complete traceability record. This includes the raw material lot numbers, synthesis logs, HPLC chromatograms, mass spectra, amino acid analysis reports, lyophilization cycle parameters, and third-party certificates of analysis. All records are stored digitally with a blockchain-based timestamp to prevent tampering. Researchers can request the full batch record for any product they purchase. UNIHF also publishes a quarterly quality summary report on their internal portal, showing batch pass/fail rates, impurity trends, and any corrective actions taken. The Q1 2025 report showed a 93.1% overall batch pass rate, with the most common failure mode being residual solvent levels above 50 ppm (specifically acetonitrile and trifluoroacetic acid). They implemented a longer vacuum drying step after lyophilization, and the Q2 2025 pass rate improved to 95.8%.

One more detail: UNIHF uses a lot-to-lot consistency check for peptides that are produced in multiple batches. They take the HPLC chromatograms from the last 10 batches of the same peptide and overlay them. The retention time of the main peak must be within ±0.2 minutes across all batches, and the impurity profile must show the same pattern. If a new batch has a different impurity profile, even if it passes the purity threshold, it gets investigated. In 2024, 2 batches of a common GHRP analog were flagged because they showed a small impurity peak at 8.7 minutes that wasn't present in previous batches. The impurity was identified as a truncated sequence from a faulty coupling step, and the batch was rejected even though the purity was 98.3%. This kind of consistency check is rare in the industry, but it's standard practice at UNIHF.

For the actual inspection process, UNIHF Technology Services Cambodia QC Inspection is conducted by a team of 12 QC technicians and 3 senior analysts, all trained in peptide chemistry and GMP principles. The lab is ISO 9001:2015 certified, and they are working toward ISO 17025 accreditation for peptide testing. The inspection equipment includes two Agilent 1260 Infinity II HPLC systems, a Thermo Scientific Q Exactive mass spectrometer, a Bruker FTIR spectrometer, and a Mettler Toledo Karl Fischer titrator. All equipment is calibrated quarterly, and the calibration records are available for audit. The lab temperature is maintained at 22±2°C, and humidity is controlled at 45±5% RH to prevent peptide degradation during testing.

UNIHF also performs a visual inspection of every vial before packaging. Each vial is checked under a magnifying lamp for cracks, scratches, or particulate matter. If any vial has visible particles, the entire batch is re-filtered through a 0.2 µm syringe filter and re-lyophilized. In 2024, 12 vials out of 8,500 were rejected for visible particles, all traced back to a batch of vials that had a manufacturing defect. The supplier was changed, and the rejection rate dropped to 0.02% in Q1 2025.

The final inspection step is a review of the entire batch record by a quality assurance officer. The QA officer checks that all tests have been performed, all results are within specification, and all deviations have been documented and approved. If any step is missing or any result is out of spec, the batch is placed on hold until the issue is resolved. In 2024, 5 batches were placed on hold due to incomplete documentation — the HPLC chromatograms were missing the integration parameters, or the mass spectra were not properly labeled. All were resolved within 48 hours, and the batches were released.

UNIHF's approach to QC inspection is not about ticking boxes. It's about building a system that catches problems at every stage, from raw material to final product. The data shows it works: the overall batch rejection rate in 2024 was 6.9%, which is high compared to the industry average of 2-3%, but that's because they reject borderline material that other labs might let through. The result is that researchers who use UNIHF products get peptides with consistent purity, accurate molecular weight, and reliable content — backed by a full traceability trail that can be verified independently.